 EyePoint Pharmaceuticals Inc NASDAQ: EYPT has priced an underwritten public offering of 4.03 million at 13.75 per share and pre-funded warrants to purchase up to an aggregate of 3.27 million shares at 13.74 per pre-funded warrant. The offer price represents a discount of 5 from the last close price of 14.50 on Tuesday. 